News for Mesa Laboratories, Inc. (MLAB)

Mesa Laboratories (MLAB) announces consistent $0.16/share dividend. Forward yield 0.59%. Key dates: Ex-div May 30, payable June 16.

**media[588388]**

Shares of Mesa Laboratories Inc (MLAB) surged 3.16% in mid-day trading on Mar 27. The stock reached an intraday high of $126.00, before settling at $125.74,

IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX), a leading American titanium metal and critical materials company, is pleased to announce two significant a

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.

**media[531677]**

**media[518108]**

On December 31, 2024, Conestoga Capital Advisors, LLC (Trades, Portfolio) made a significant addition to its portfolio by acquiring 89,001 shares of Mesa Labora

**media[507366]**

Mesa Laboratories' recent acquisition of GKE has improved ROICs, but the legacy business remains a drag on overall performance. Read my analysis of MLAB stock.

MIND Technology (MIND) experienced a notable stock surge of 5.29%, reaching $4.18 per share with a trading volume of 111,839 shares and a turnover rate of 1.40%

Shares of Mesa Laboratories Inc (MLAB) surged 3.56% in mid-day trading on Oct 30. The stock reached an intraday high of $116.73, before settling at $116.69,

Mesa Laboratories CEO sells shares valued at $571,735

Shares of Mesa Laboratories Inc (MLAB) fell 5.37% in mid-day trading on Oct 23. The stock reached an intraday low of $126.80, down from its previous close of

Overview of Chuck Royce (Trades, Portfolio)'s Recent Trade On September 30, 2024, the investment firm managed by Chuck Royce (Trades, Portfolio) executed a sign

Shares of Mesa Laboratories Inc (MLAB) fell 4.63% in mid-day trading on Oct 7. The stock reached an intraday low of $127.29, before recovering slightly to $12

FARO Technologies (FARO) saw its stock price fluctuate, dropping by 5.02%. The stock is currently trading at $18.18 per share with a trading volume of 53,352 sh

Q2 '24 may be best remembered as a period of moderation. Economic indicators largely reflected slowing growth and easing inflation. Click here to read more.

In a Technical Strategy report, Roth MKM analysts said that health care (PSCH), (XLV) will continue to ascend in their rankings.